Rotarex治疗股腘动脉支架内再狭窄的现状及展望  

Rotarex atherectomy system for the treatment of femoropopliteal in-stent restenosis: current status and perspectives

作　　者：郭晓博 刘明远 冯海[1] GUO Xiaobo;LIU Mingyuan;FENG Hai(Department of Vascular Surgery,Beijing Friendship Hospital,Capital Medical University,Beijing 100050,China)

机构地区：[1]首都医科大学附属北京友谊医院血管外科,北京100050

出　　处：《中国普通外科杂志》2022年第12期1674-1679,共6页China Journal of General Surgery

基　　金：首都卫生发展科研专项基金资助项目(首发2020-2-1102)。

摘　　要：支架内再狭窄(ISR)是股腘动脉(FP)疾病介入治疗术后面临的一个重要临床问题。初次置入支架的FP-ISR发生率较高,并且反复的ISR往往需要多次后续手术治疗。前期的研究集中在球囊血管成形术、搭桥手术、覆膜支架、药物球囊、减容治疗,但最佳治疗方案仍有争议。近期的治疗方案已转向两种或多种方法的联合治疗。其中以Rotarex斑块切除术加减容为基础的联合治疗成为FP-ISR治疗的一种新选择。笔者就Rotarex联合治疗应用于FP-ISR的安全性和有效性进行分析,并讨论未来的前景。In-stent restenosis(ISR) is a challenging clinical problem after intervention therapy of femoropopliteal(FP) arterial occlusive disease. Femoropopliteal artery in-stent restenosis(FP-ISR) rates after primary stent implantation are relatively high, and repeat FP-ISR often requires multiple additional interventions. Previous studies mainly focused on balloon angioplasty, bypass surgery, stent-graft, drug-coated balloon, and debulking therapies. However, the optimal approach remains controversial. Recently, the treatment trend has shifted to a combination of two or more methods. Among them, the combination therapy based on Rotarex atherectomy plus debulking has become a new choice for FP-ISR. Here, the authors analyze the safety and efficacy of Rotarex combination therapy used for FP-ISR and also discuss the future prospects.

关 键 词：外周血管疾病 支架 移植物闭塞 血管 综述 

分 类 号：R654.3[医药卫生—外科学]